Webinar: Overcoming the challenges in deploying new imaging biomarkers in clinical trials

Live Webinar: Overcoming the challenges in deploying new imaging biomarkers in clinical trials – Perspectives from patients, physicians, and other stakeholders

This webinar is jointly organized by Labcorp Drug Development and Median Technologies. New Imaging biomarkers have a solid potential to provide additional insight for clinical trials: better selection of patients, prediction of response to therapy, and early assessments of drug effects and safety. However, implementing them in clinical trials often promote challenges. This webinar aims to discuss these challenges from the perspective of patients, physicians, and the different stakeholders involved in the oncology clinical trials.

During this webinar, you will learn the following:
1. The value of modern imaging technologies in oncology trials
2. The challenges linked to the implementation of new imaging biomarkers
3. How AI-powered imaging optimizes clinical trial design

Our presenter panel includes high-level experts:
• Dr. Yumin Zhang, Chief Medical Officer and Vice President, Huayi Technology CO LTD
• Dr. Ravi Karra, M.D, Senior Medical Director Oncology, Labcorp Drug Development
• Dr. Yan Liu, Chief Medical Officer, Median Technologies.